Monthly Archives: January 2009

MedReg Wins the Battles, Loses the War

In pharmaceutical companies there is a department called Medical/Regulatory, MedReg for short, that among other things, reviews promotional communications content and form to ensure that it falls within the heavily drawn regulatory parameters outlined by the FDA.  MedReg is made … Continue reading

Posted in New and Social Media | Comments Off

Morningstar on the Wyeth/Pfizer News

Share this:

Posted in Business/Industry News | Comments Off

The Importance of Being Washington – The GAO Outlines FDA Reforms

Not the man, the city.   On Sunday, January 25, the Washington Post carried an article entitled "The Height of Power – As Other American Fiefdoms Fade, Washington Looms Larger than Ever."  It was a very interesting article analyzing the current … Continue reading

Posted in Legislation | Comments Off

Weekly Roundup – 01/23/09

Late posting today – Typepad was curiously uncooperative today.   This week we saw the end of one Administration and the beginning of another, but we also saw more than that.  We saw that America once again stood apart from … Continue reading

Posted in Weekly Roundup | Comments Off

The New Acting FDA Commissioner – Frank Torti

We have seen the big change with the Inauguration of President Obama.  In our smaller world concerned with the FDA, there has also been significant change.  Dr. Andrew C. von Eschenbach has left the FDA effective January 20, leaving Dr. … Continue reading

Posted in FDA Image | Comments Off